San Diego's Scripps Translational Science Institute will conduct the first study to assess whether people taking genetic tests will change their behavior, says this article in SciAm. Scripps will offer its 10,000 employees, family members, and friends of the nonprofit Scripps Health system Navigenics' genetic test, and changes in behavior will be assessed over a 20-year period. The study will be led by Eric Topol, director at Scripps.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.